Related references
Note: Only part of the references are listed.The neural stem cell secretome and its role in brain repair
Cory M. Willis et al.
BRAIN RESEARCH (2020)
Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease
Fabio G. Teixeira et al.
CELLS (2020)
N-acetylcysteine Provides Cytoprotection in Murine Oligodendrocytes through Heme Oxygenase-1 Activity
Jie Zhou et al.
BIOMEDICINES (2020)
Harnessing the Neural Stem Cell Secretome for Regenerative Neuroimmunology
Cory M. Willis et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
The protective effects of the antioxidant N-acetylcysteine (NAC) against oxidative stress-associated apoptosis evoked by the organophosphorus insecticide malathion in normal human astrocytes
Pochuen Shieh et al.
TOXICOLOGY (2019)
N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease
Daniel A. Monti et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model
Barbara Mendes-Pinheiro et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
Safinamide: a new hope for Parkinson's disease?
Fabio G. Teixeira et al.
DRUG DISCOVERY TODAY (2018)
Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease
Barbara Mendes-Pinheiro et al.
STEM CELLS TRANSLATIONAL MEDICINE (2018)
Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease
Fabio G. Teixeira et al.
STEM CELLS TRANSLATIONAL MEDICINE (2017)
Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments
Panchanan Maiti et al.
TRANSLATIONAL NEURODEGENERATION (2017)
Mesenchymal stem cells secretome-induced axonal outgrowth is mediated by BDNF
Lus F. Martins et al.
SCIENTIFIC REPORTS (2017)
N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data
Daniel A. Monti et al.
PLOS ONE (2016)
N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases
Mary J. Holmay et al.
CLINICAL NEUROPHARMACOLOGY (2013)
N-Acetylcysteine Prevents Loss of Dopaminergic Neurons in the EAAC1-/- Mouse
Ari E. Berman et al.
ANNALS OF NEUROLOGY (2011)
Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in α-Synuclein Overexpressing Mice
Joanne Clark et al.
PLOS ONE (2010)
Quinone and oxyradical scavenging properties of N-acetylcysteine prevent dopamine mediated inhibition of Na+, K+-ATPase and mitochondrial electron transport chain activity in rat brain: Implications in the neuroprotective therapy of Parkinson's disease
Maria B. Bagh et al.
FREE RADICAL RESEARCH (2008)
Antioxidative and anti-inflammatory effects of four cysteine-containing agents in striatum of MPTP-treated mice
Chiu-Mei Chen et al.
NUTRITION (2007)
N-Acetylcysteine elicited increase in complex I activity in synaptic mitochondria from aged mice:: implications for treatment of Parkinson's disease
MM Banaclocha
BRAIN RESEARCH (2000)
Share Paper
